ESRP2 and hepatocellular carcinoma: [33] In the present study, we found that hypermethylation of the ESRP2 promoter was the major cause of ESRP2 downregulation in HCC, which explains the “turn off” mechanism of oncofetal suppressors in tumor tissues.